Levetiracetam Injection (IV) bulk supplier for pharma manufacturers

Levetiracetam Injection (IV) 100 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injection (IV)

Available Strengths: 100 mg/mL

Reference Brands: US: Keppra®, Keppra XR®; EU: Keppra®, EpiKeppra®

Levetiracetam IV acts by binding to the synaptic vesicle protein SV2A, modulating neurotransmitter release and stabilizing neuronal activity. It is used for treating seizures, including partial-onset, myoclonic, and generalized tonic-clonic seizures. The IV form is ideal for acute seizure management when oral administration is not feasible. Levetiracetam Injection (IV) is FDA-approved in the USA for the treatment of partial-onset, myoclonic, and generalized tonic-clonic seizures in various age groups when oral administration is not possible. It follows strict GMP standards and carries labeling requirements for CNS effects and neuropsychiatric warnings. In the European Union, Levetiracetam IV is approved through centralized or national procedures with emphasis on Risk Management Plans (RMPs) and Periodic Safety Update Reports (PSURs). It must demonstrate bioequivalence for generic versions. Explore high-quality Levetiracetam IV products and global B2B sourcing opportunities at Pharmatradz.com.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Levetiracetam Injection (IV)? List it or send an offer →

Product Description: Levetiracetam, marketed globally under brands like Keppra®, is a widely prescribed anticonvulsant used for treating epilepsy. Available in the US and EU, Levetiracetam comes in oral tablets (250 mg–1000 mg), oral solution (100 mg/mL), and injectable forms. This drug is effective in managing partial, generalized, and myoclonic seizures in adults and children. Its high tolerability and minimal drug interactions make it a preferred option among neurologists. Pharmatradz.com helps you connect with certified global B2B suppliers of Levetiracetam API, formulations, and bulk stock across regulated markets. Source top-quality Levetiracetam from audited manufacturers via Pharmatradz.

Levetiracetam Injection (IV) — third party manufacturing & bulk supply

Levetiracetam Injection (IV) 100 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Levetiracetam Injection (IV) is supplied as Injection (IV) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Levetiracetam Injection (IV) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Levetiracetam Injection (IV) →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Levetiracetam Injection (IV) is listed as Injection (IV) in 100 mg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Levetiracetam Injection (IV) is referenced against US: Keppra®, Keppra XR®; EU: Keppra®, EpiKeppra®. Reference brands are shown for identification only and remain the property of their respective trademark owners.